1. Home
  2. ASIX vs RAPP Comparison

ASIX vs RAPP Comparison

Compare ASIX & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASIX
  • RAPP
  • Stock Information
  • Founded
  • ASIX 2016
  • RAPP 2022
  • Country
  • ASIX United States
  • RAPP United States
  • Employees
  • ASIX N/A
  • RAPP N/A
  • Industry
  • ASIX Major Chemicals
  • RAPP
  • Sector
  • ASIX Industrials
  • RAPP
  • Exchange
  • ASIX Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • ASIX 526.1M
  • RAPP 439.4M
  • IPO Year
  • ASIX N/A
  • RAPP 2024
  • Fundamental
  • Price
  • ASIX $19.79
  • RAPP $24.99
  • Analyst Decision
  • ASIX Buy
  • RAPP Strong Buy
  • Analyst Count
  • ASIX 1
  • RAPP 4
  • Target Price
  • ASIX $32.00
  • RAPP $37.00
  • AVG Volume (30 Days)
  • ASIX 250.1K
  • RAPP 578.1K
  • Earning Date
  • ASIX 11-07-2025
  • RAPP 11-06-2025
  • Dividend Yield
  • ASIX 3.26%
  • RAPP N/A
  • EPS Growth
  • ASIX 829.30
  • RAPP N/A
  • EPS
  • ASIX 2.84
  • RAPP N/A
  • Revenue
  • ASIX $1,515,062,000.00
  • RAPP N/A
  • Revenue This Year
  • ASIX $7.41
  • RAPP N/A
  • Revenue Next Year
  • ASIX $4.60
  • RAPP N/A
  • P/E Ratio
  • ASIX $6.91
  • RAPP N/A
  • Revenue Growth
  • ASIX 1.31
  • RAPP N/A
  • 52 Week Low
  • ASIX $17.97
  • RAPP $6.43
  • 52 Week High
  • ASIX $33.00
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • ASIX 44.09
  • RAPP 48.50
  • Support Level
  • ASIX $19.18
  • RAPP $24.87
  • Resistance Level
  • ASIX $20.89
  • RAPP $27.03
  • Average True Range (ATR)
  • ASIX 0.64
  • RAPP 1.83
  • MACD
  • ASIX 0.01
  • RAPP -0.70
  • Stochastic Oscillator
  • ASIX 31.82
  • RAPP 9.03

About ASIX AdvanSix Inc.

AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: